Next Article in Journal
Modulating NPC1L1 to Potentiate PARP Inhibitor-Induced Ferroptosis and Immune Response in Triple-Negative Breast Cancer
Previous Article in Journal
The Development of Al18F-NOTA-FAP-2286 as an FAP-Targeted PET Tracer and the Translational Application in the Diagnosis of Acquired Drug Resistance in Progressive Prostate Cancer
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(5), 553; https://doi.org/10.3390/pharmaceutics17050553
Action Date Notes Link
article xml file uploaded 24 April 2025 08:33 CEST Original file -
article xml uploaded. 24 April 2025 08:33 CEST Update -
article pdf uploaded. 24 April 2025 08:33 CEST Version of Record https://www.mdpi.com/1999-4923/17/5/553/pdf-vor
article html file updated 24 April 2025 08:38 CEST Original file -
article xml file uploaded 24 April 2025 09:38 CEST Update -
article xml uploaded. 24 April 2025 09:38 CEST Update -
article pdf uploaded. 24 April 2025 09:38 CEST Updated version of record https://www.mdpi.com/1999-4923/17/5/553/pdf-vor
article html file updated 24 April 2025 09:41 CEST Update -
article xml file uploaded 28 April 2025 09:18 CEST Update -
article xml uploaded. 28 April 2025 09:18 CEST Update https://www.mdpi.com/1999-4923/17/5/553/xml
article pdf uploaded. 28 April 2025 09:18 CEST Updated version of record https://www.mdpi.com/1999-4923/17/5/553/pdf
article html file updated 28 April 2025 09:20 CEST Update https://www.mdpi.com/1999-4923/17/5/553/html
Back to TopTop